Drawing for BUILDING HEALTH CONFIDENCE

USPTO serial 99187571

BUILDING HEALTH CONFIDENCE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
YAO, GRETTA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with BUILDING HEALTH CONFIDENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Pickerill

John Pickerill Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for treatment within the fields of gastroenterology, dermatology, oncology, immune therapy, immunology, gastro retentive drug delivery systems and vaccines; Contrast media for use with medical equipment and in medical imaging; Diagnostic agents, preparations and substances for medical and surgical purposes; Dietetic substances and food adapted for medical or veterinary use, food for babies; Dietetic supplements for medical purposes for human and animal consumption; Material for stopping teeth, dental wax; Disinfectants; Preparations for destroying vermin; Fungicides, herbicidesACTIVE—
009Downloadable artificial intelligence software for the detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures; downloadable artificial intelligence software for healthcare management and administration and managing healthcare data; embedded artificial intelligence software in diagnostic devices for the detection of lesions during colonoscopy; downloadable software to assist in detecting polyps; recorded computer software and hardware used for the detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures; tablet computers; tablet computers which allow interactive access to artificial intelligence content; downloadable artificial intelligence software used for the detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures; medical computer hardware and recorded software for receiving, analyzing, managing, processing, reporting and displaying sensor data from gastrointestinal tracts and digestive systems; Software as a Medical Device (SaMD), downloadable, featuring artificial intelligence for the detection of lesions during colonoscopyACTIVE—
010Medical devices for use in chromoendoscopy and endoscopy procedures of the gastrointestinal tract; medical devices to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical instruments to aid the detection, diagnosis, prevention and treatment of gastroenterological diseases; medical devices for enhancing visualization during chromoendoscopy, endoscopy, colonoscopy, sigmoidoscopy, anoscopy, rectoscopy and proctoscopy procedures; Surgical, medical, dental and veterinary apparatus and instruments for use in the detection, diagnosis, prevention and treatment of gastroenterological diseases; artificial limbs, eyes and teeth; Suture materials; medical devices featuring artificial intelligence for the detection of lesions during colonoscopyACTIVE—
042Providing online non-downloadable artificial intelligence software for the detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures and for healthcare management and administration and managing healthcare data; Scientific and technological services and research, and design in the field of artificial intelligence for healthcare, dermatology and gastroenterology; Industrial analysis and research services; Design and development of computer hardware and software; Software as a Service and Platform as a Service featuring software and software platforms for detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures; Software as a Service and Platform as a Service featuring software and software platforms incorporating artificial intelligence for detection, identification and diagnosis of lesions and other pathology in gastrointestinal tracts and digestive systems during colonoscopy, endoscopy, or gastroscopy procedures; Software as a Service and Platform as a Service featuring software and software platforms for detecting polyps; Software as a Service and Platform as a Service featuring software and software platforms for receiving, analyzing, managing, processing, reporting and displaying sensor data from gastrointestinal tracts and digestive systemsACTIVE—
044Providing health care information by the internet; pharmaceutical advice; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jun 2, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 8, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 8, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 2, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 2, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 1, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 29, 2025DOCKASSIGNED TO EXAMINER—
May 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance